Tag Archives: comparative effectiveness

UK payors push OFF LABEL use for cost savings

Interesting article in the online Financial Times yesterday which describes the ongoing debate over off-label usage of Avastin(R) in lieu of the much more expensive Lucentis(R) for treatement of wet AMD.  Over the recommendation of their own specialist ophthalmic association! … Continue reading

Posted in Uncategorized | Tagged , , , , | Comments Off